Application of 3-TYP in preparation of medicine for treating autoimmune demyelination disease
The invention belongs to the technical field of medicines, and discloses application of 3-TYP shown in a formula (I) in preparation of medicines for preventing, relieving and/or treating autoimmune demyelination diseases. In a mouse experimental autoimmune encephalomyelitis model, the 3-TYP shows a good treatment effect, and can effectively treat pathological changes and progression of diseases. The therapeutic effect is achieved by relieving spinal cord inflammatory cell infiltration and reducing spinal cord demyelination, and relieving spinal cord inflammation and inhibiting generation of proinflammatory factors may be achieved by adjusting the polarization state of M1/M2 type microglial cells..
Medienart: |
Patent |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Europäisches Patentamt - (2023) vom: 29. Aug. Zur Gesamtaufnahme - year:2023 |
---|
Sprache: |
Englisch |
---|
Beteiligte Personen: |
DU GUANHUA [VerfasserIn] |
---|
Links: |
Volltext [kostenfrei] |
---|
Themen: |
Sonstige Themen: |
---|
Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2023-08-29, Last update posted on www.tib.eu: 2023-12-05, Last updated: 2023-12-08 |
---|
Patentnummer: |
CN116650482 |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
EPA01852317X |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | EPA01852317X | ||
003 | DE-627 | ||
005 | 20231208115243.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231117s2023 xx |||||o 00| ||eng c | ||
035 | |a (DE-627)EPA01852317X | ||
035 | |a (EPA)CN116650482 | ||
035 | |a (EPA)87722920 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 0 | |a DU GUANHUA |e verfasserin |4 aut | |
245 | 1 | 0 | |a Application of 3-TYP in preparation of medicine for treating autoimmune demyelination disease |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Source: www.epo.org (no modifications made), First posted: 2023-08-29, Last update posted on www.tib.eu: 2023-12-05, Last updated: 2023-12-08 | ||
520 | |a The invention belongs to the technical field of medicines, and discloses application of 3-TYP shown in a formula (I) in preparation of medicines for preventing, relieving and/or treating autoimmune demyelination diseases. In a mouse experimental autoimmune encephalomyelitis model, the 3-TYP shows a good treatment effect, and can effectively treat pathological changes and progression of diseases. The therapeutic effect is achieved by relieving spinal cord inflammatory cell infiltration and reducing spinal cord demyelination, and relieving spinal cord inflammation and inhibiting generation of proinflammatory factors may be achieved by adjusting the polarization state of M1/M2 type microglial cells. | ||
650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
650 | 4 | |a A61P: Specific therapeutic activity of chemical compounds or medicinal preparations | |
650 | 4 | |a che | |
650 | 4 | |a 615 | |
700 | 0 | |a LI LI |4 aut | |
700 | 0 | |a SHEN YANJIA |4 aut | |
700 | 0 | |a ZHAO JIAYING |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2023) vom: 29. Aug. |
773 | 1 | 8 | |g year:2023 |g day:29 |g month:08 |
856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/87722920/publication/CN116650482A1?q=CN116650482 |z kostenfrei |3 Volltext |
912 | |a GBV_EPA | ||
936 | u | w | |j 2023 |b 29 |c 08 |
951 | |a AR | ||
952 | |j 2023 |b 29 |c 08 |